1. Home
  2. WAL vs NUVL Comparison

WAL vs NUVL Comparison

Compare WAL & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Alliance Bancorporation (DE)

WAL

Western Alliance Bancorporation (DE)

HOLD

Current Price

$91.20

Market Cap

9.7B

Sector

Finance

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$105.01

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAL
NUVL
Founded
1994
2017
Country
US
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.0B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WAL
NUVL
Price
$91.20
$105.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
15
Target Price
$101.40
$135.00
AVG Volume (30 Days)
1.1M
459.8K
Earning Date
01-01-0001
04-14-2026
Dividend Yield
1.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.16
N/A
Revenue Next Year
$8.63
N/A
P/E Ratio
$10.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.05
$55.54
52 Week High
$97.23
$113.02

Technical Indicators

Market Signals
Indicator
WAL
NUVL
Relative Strength Index (RSI) 49.52 52.71
Support Level $91.80 $98.50
Resistance Level $96.51 $106.57
Average True Range (ATR) 3.31 4.72
MACD -0.15 -0.07
Stochastic Oscillator 35.97 60.79

Price Performance

Historical Comparison
WAL
NUVL

About WAL Western Alliance Bancorporation (DE)

Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: